216 related articles for article (PubMed ID: 4318268)
21. Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle.
Saravanan P; Sreenivasa BP; Selvan RP; Basagoudanavar SH; Hosamani M; Reddy ND; Nathanielsz J; Derozier C; Venkataramanan R
Vaccine; 2015 Jan; 33(5):670-7. PubMed ID: 25528522
[TBL] [Abstract][Full Text] [Related]
22. Enhanced immune responses of foot-and-mouth disease vaccine using new oil/gel adjuvant mixtures in pigs and goats.
Park ME; Lee SY; Kim RH; Ko MK; Lee KN; Kim SM; Kim BK; Lee JS; Kim B; Park JH
Vaccine; 2014 Sep; 32(40):5221-7. PubMed ID: 25066738
[TBL] [Abstract][Full Text] [Related]
23. The performance of southern African territories serotypes of foot and mouth disease antigen in oil-adjuvanted vaccines.
Hunter P
Rev Sci Tech; 1996 Sep; 15(3):913-22. PubMed ID: 9025141
[TBL] [Abstract][Full Text] [Related]
24. Promising MS2 mediated virus-like particle vaccine against foot-and-mouth disease.
Dong YM; Zhang GG; Huang XJ; Chen L; Chen HT
Antiviral Res; 2015 May; 117():39-43. PubMed ID: 25676866
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of a bivalent anti-foot-and-mouth disease vaccine with oil adjuvant to a vaccine with DEAE-dextran adjuvant in swine].
Kihm U
Dev Biol Stand; 1976; 35():149-53. PubMed ID: 198281
[TBL] [Abstract][Full Text] [Related]
26. [Effect of pretreatment by immunity adjuvants on the multiplication of foot-and-mouse disease virus in adult mouse].
Gorhe D; Asso J; Paraf A
Ann Inst Pasteur (Paris); 1968 Sep; 115(3):446-64. PubMed ID: 4304117
[No Abstract] [Full Text] [Related]
27. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
[TBL] [Abstract][Full Text] [Related]
28. Immune response of steers inoculated with chemically-treated foot-and-mouth disease virus preparations previously studied in swine.
McKercher PD; Giordano AR
Arch Gesamte Virusforsch; 1967; 20(2):190-7. PubMed ID: 4299724
[No Abstract] [Full Text] [Related]
29. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
Dunn CS; Samuel AR; Pullen LA; Anderson J
Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
[TBL] [Abstract][Full Text] [Related]
30. Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus.
Mulcahy G; Reid E; Dimarchi RD; Gale C; Doel TR
Res Vet Sci; 1992 Mar; 52(2):133-40. PubMed ID: 1316628
[TBL] [Abstract][Full Text] [Related]
31. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.
Xiao C; Jin H; Hu Y; Kang Y; Wang J; Du X; Yang Y; She R; Wang B
Antiviral Res; 2007 Oct; 76(1):11-20. PubMed ID: 17540462
[TBL] [Abstract][Full Text] [Related]
32. [Riems foot-and-mouth disease oil emulsion vaccines for swine. 2. Use of foot-and-mouth 2-component oil emulsion vaccines in practice].
Nöckler A; Thalmann G; Haack P; Nehmzow P; Poewe R; Pietzsch E; Seils G
Arch Exp Veterinarmed; 1990; 44(2):183-8. PubMed ID: 2167045
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of the immune response elicited with foot-and-mouth disease virus vaccines by an extract of the Mycobacterium sp. wall.
Berinstein A; Piatti P; Gaggino OP; Schudel AA; Sadir AM
Vaccine; 1991 Dec; 9(12):883-8. PubMed ID: 1667346
[TBL] [Abstract][Full Text] [Related]
34. Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission.
Salt JS; Barnett PV; Dani P; Williams L
Vaccine; 1998 Apr; 16(7):746-54. PubMed ID: 9562696
[TBL] [Abstract][Full Text] [Related]
35. [Local reactions following vaccination of swine with foot-and-mouth disease (FMD) vaccines containing Freund's adjuvant].
Wittmann G; Bauer K
Berl Munch Tierarztl Wochenschr; 1969 Jan; 82(1):2-4. PubMed ID: 5388110
[No Abstract] [Full Text] [Related]
36. [Analysis of the immunologic properties of foot-and-mouth disease vaccines].
Tekerlekov P; Gergov P; Nikolova E
Vet Med Nauki; 1982; 19(3):29-34. PubMed ID: 6291225
[No Abstract] [Full Text] [Related]
37. Immune response of neonatal swine to inactivated foot-and-mouth disease virus vaccine with oil adjuvant. I. Influence of colostral antibody.
Morgan DO; McKercher PD
Proc Annu Meet U S Anim Health Assoc; 1977; (81):244-55. PubMed ID: 220635
[No Abstract] [Full Text] [Related]
38. [Efficacy testing of anti-foot-and-mouth disease vaccines in guinea pigs using myotropic strains].
Eissner G; Böhm HO
Dev Biol Stand; 1976; 35():279-83. PubMed ID: 198295
[No Abstract] [Full Text] [Related]
39. [Studies on the suitability of tissue culture neutralization tests in the government etesting of adsorbed foot-and mouth disease vaccines. 1. The content of neutralizing antibody in the serum of cattle after vaccination with adsorbed vaccine against type O2 virus in comparison with the direct immunity testing in cattle].
Rüting E; Seils H; Weyhe D; Benndorf E
Arch Exp Veterinarmed; 1969; 23(4):827-38. PubMed ID: 4319494
[No Abstract] [Full Text] [Related]
40. [Further studies on delayed type foot-and-mouth disease allergy].
Mayr A; Thein P; Baljer G
Zentralbl Veterinarmed B; 1970 Nov; 17(9):905-17. PubMed ID: 4326186
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
